noom glp 1 reviews negative I’m not anti-GLP1’s…but I AM anti…, 1️⃣ The message: “Whatever size you are, you should be smaller”, 2️⃣ Slaps the word “longevity” on top, 3️⃣ And ties it with a pretty bow of “preventative health”, GLP-1s can support change -

Promising new candidates include: Amycretin (Novo Nordisk) Orforglipron (Eli Lilly) Survodutide (Boehringer Ingelheim) VK2735 (Viking Therapeutics) MariTide (Amgen) Retatrutide (Eli Lilly) Among the most closely watched candidates is retatrutide, a triple-agonist developed by Eli Lilly that targets GLP-1, GIP, and glucagon receptors

I may not be postulating this right, but the \ B12 and B9 are so inter-related

Ask your doctor about what you can expect, how to address them, and any interactions GLP-1s may have with your current medications

Serhan CN, Levy BD

Khezri MR, Yousefi K, Mahboubi N, Hodaei D, Ghasemnejad-Berenji M